Angiotensin-converting enzyme inhibitors reduce hemoglobin concentrations, hematocrit, and serum erythropoietin levels in renal transplant recipients without posttransplant erythrocytosis.
Montanaro
D
D
Division of Nephrology, "S. Maria della Misericordia" Hospital, Udine, Italy. domont@tin.it
Gropuzzo
M
M
Tulissi
P
P
Boscutti
G
G
Risaliti
A
A
Baccarani
U
U
Mioni
G
G
D000328:Adult; D000704:Analysis of Variance; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D004921:Erythropoietin / Q000097:blood*; D005260:Female; D006400:Hematocrit; D006454:Hemoglobins / Q000187:drug effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D011086:Polycythemia / Q000097:blood*; D011183:Postoperative Complications / Q000097:blood*; D012189:Retrospective Studies
D000806:Angiotensin-Converting Enzyme Inhibitors; D006454:Hemoglobins; D007166:Immunosuppressive Agents; D004921:Erythropoietin